Devising Advanced TCR-T cells to eradicate OsteoSarcoma
Devising Advanced TCR-T cells to eradicate OsteoSarcoma
Johannes Zuber
(ORCID: 0000-0001-8810-6835)
Disciplines
Clinical Medicine (30%); Medical-Theoretical Sciences, Pharmacy (50%); Medical Engineering (20%)
Keywords
-
Cancer immunotherapy,
TCR-T cells,
Pediatric osteosarcoma,
T cell engineering,
CRISPR/Cas9 screens,
Single-cell multi-omics
Consortium
-
consortium member (1.2.2023 - )
-
consortium member (1.2.2023 - )
-
consortium member (1.2.2023 - )
-
principal investigator (1.2.2023 - )
-
consortium member (1.2.2023 - )
-
consortium member (1.2.2023 - )
Research institution(s)
Project participants
- Leo Kager, St. Anna Kinderkrebsforschung GmbH , national collaboration partner
International project participants
- Piotr Rutkowski, Maria Sklodowska-Curie Institute - Poland
- E. Alejandro Sweet-Cordero, University of California San Francisco - USA